Efficacy of Extended-Release Liposomal Bupivacaine for Post-Partum Pain Management Following Obstetrical Laceration: A Prospective, Randomized, Single-Blinded Trial
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2019
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine
- Indications Postpartum pain
- Focus Therapeutic Use
- 11 Jul 2019 Status changed from recruiting to completed.
- 09 May 2018 Planned End Date changed from 1 Jul 2018 to 1 Nov 2018.
- 09 May 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Nov 2018.